BASELINE CD4+CD25+CD127LOW/- TREGS AND ITS EARLY DYNAMIC CHANGES PREDICTS 24 WEEKS TREATMENT EFFICACY IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS PATIENTS - A SINGLE CENTER EXPERIENCE FROM 54 PATIENTS TREATED WITH TELBIVUDINE (LDT)
第一作者单位：[1]Huazhong Univ Sci & Technol, Dept & Inst Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China
推荐引用方式(GB/T 7714)：
Yan Weiming,Wang Xiaojing,Guo Wei,et al.BASELINE CD4+CD25+CD127LOW/- TREGS AND ITS EARLY DYNAMIC CHANGES PREDICTS 24 WEEKS TREATMENT EFFICACY IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS PATIENTS - A SINGLE CENTER EXPERIENCE FROM 54 PATIENTS TREATED WITH TELBIVUDINE (LDT)[J].HEPATOLOGY.2010,52(4):562A-563A.
APA：
Yan,Weiming,Wang,Xiaojing,Guo,Wei,Xu,Li,Sun, Ying...&Ning, Qin.(2010).BASELINE CD4+CD25+CD127LOW/- TREGS AND ITS EARLY DYNAMIC CHANGES PREDICTS 24 WEEKS TREATMENT EFFICACY IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS PATIENTS - A SINGLE CENTER EXPERIENCE FROM 54 PATIENTS TREATED WITH TELBIVUDINE (LDT).HEPATOLOGY,52,(4)
MLA：
Yan,Weiming,et al."BASELINE CD4+CD25+CD127LOW/- TREGS AND ITS EARLY DYNAMIC CHANGES PREDICTS 24 WEEKS TREATMENT EFFICACY IN HEPATITIS B E ANTIGEN POSITIVE CHRONIC HEPATITIS PATIENTS - A SINGLE CENTER EXPERIENCE FROM 54 PATIENTS TREATED WITH TELBIVUDINE (LDT)".HEPATOLOGY 52..4(2010):562A-563A
医学